Over the Counter (OTC) Drugs Market Future Scope and Competitive Analysis by Alkem Labs, Reckitt Benckiser Group plc., Piramal Enterprises Ltd., , Cipla, Pfizer Inc., Procter & Gamble, Perrigo Company plc

The Over the Counter (OTC) Drugs Market research report strongly analyses the potential of the market with respect to existing scenario and the future prospects by considering all industry aspects of Pharmaceutical industry. This market report contains historic data along with future forecast and detailed analysis for the market on a global and regional level. Market analysis and market segmentation has been carried out in terms of markets, geographic scope, years considered for the study, currency and pricing, research methodology, primary interviews with key opinion leaders, DBMR market position grid, DBMR market challenge matrix, secondary sources, and assumptions.

Click Here To Get Global Over the Counter (OTC) Drugs Market Research Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-over-the-counter-otc-drugs-market

Major competitors currently working in the global over the counter (OTC) drugs market are:

Johnson & Johnson Services, Inc., Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Sanofi, F. Hoffmann-La Roche Ltd, Bayer AG, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Novartis AG, Sun Pharmaceutical Industries Ltd., Alkem Labs, Reckitt Benckiser Group plc., Piramal Enterprises Ltd., , Cipla, Pfizer Inc., Procter & Gamble, Perrigo Company plc, Mylan N.V., DAIICHI SANKYO COMPANY, LIMITED among others.

Global Over the Counter (OTC) Drugs Market By Products Type (Analgesics, Cold, Cough & Flu Products, Gastrointestinal Products, Ophthalmic Products, Dermatology Products, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and  Forecast to 2026 over the counter (OTC) drugs market is rising gradually with a substantial CAGR of 8.7% in the forecast period of 2019-2026. Adoption of OTC drugs by many pharmaceutical companies and usage by general people over prescription drugs brings a great opportunity to the market growth.

Market Definition:

Over The Counter (OTC) drugs are medications that can be taken without the consultation from healthcare professionals by the general public based on the safety and efficacy of the drugs. Some examples of OTC drugs are acetaminophen (paracetamol) and ibuprofen for pain relief, dextromethorphan and cough suppressants. These drugs are safe and effective and are used for the treatment of conditions that do not require the direct consultation of any doctor. OTC drugs are available in all pharmacies and others places such as grocery stores and gas stations.

According to the Consumer Healthcare Products Association, the use of OTCs has given rise to the allergy sufferers from 66% (2009) to 75% (2015). An estimated to 81% of adults prefer to use OTC medications as primary option for minor diseases and conditions.

Market Drivers

Favorable regulatory policies and conditions for approval of OTC drugs will boost the market growth in the forecast period
Increasing geriatric population which is highly susceptible to several diseases such as joint pain is another factor uplifting the growth of this market
Affordable cost associated with OTC drugs is a major driver of market growth
Increasing patent expirations of many drugs resulting in use as OTC drugs drives the market growth

Market Restraints

Lack of health and OTC products awareness in rural areas is an obstruction to the market growth
Incorrect diagnosis results in inappropriate use of OTC drugs acting as restrain to the market growth
Competition amongst the existing players is another factor restricting this market growth

Table Of Contents: Global Over the Counter (OTC) Drugs Market

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse TOC with selected illustrations and example pages of Global Over the Counter (OTC) Drugs Market @ https://www.databridgemarketresearch.com/toc/?dbmr=global-over-the-counter-otc-drugs-market

Segmentation: Global Over the Counter (OTC) Drugs Market

By Products Type

Analgesics
Cold, Cough & Flu Products
Gastrointestinal Products
Ophthalmic Products
Dermatology Products
Others

By End Users

Hospitals
Homecare
Specialty Clinics
Others

By Distribution Channels

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others

By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Key Developments in the Market:

In July 2019, Sanofi announced an agreement with F. Hoffmann-La Roche Ltd to get the exclusive OTC rights to Tamiflu, an antiviral drug used for the prevention and treatment of patients with influenza or flu. By this agreement, Sanofi will handle the FDA negotiation for the OTC switch and receive the marketing and distribution rights of Tamiflu in the United States
In March 2018, GlaxoSmithKline plc purchased 36.5% stake in the Consumer Healthcare Joint Venture from Novartis AG. This agreement provides GlaxoSmithKline plc business of sensodyne toothpaste and over-the-counter pills from Novartis AG. By this deal, GlaxoSmithKline plc will own the OTC business of the company and Novartis AG will be enabled to focus on its core businesses

Competitive Analysis:

Global over the counter (OTC) drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of over the counter (OTC) drugs market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global over the counter (OTC) drugs market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Any Questions? Inquire here before the purchase of Over the Counter (OTC) Drugs Market @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-over-the-counter-otc-drugs-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.